 The primary objective of the trial was to assess the bioequivalence for two concentrations 5.83 mgmL and 8 mgmL of the new r-hGH liquid multidose formulation using the r hGH freeze-dried multidose formulation Saizen 8 mg, 8.8 mg1.51 mL as reference. 